Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Cardiol

Retrieve available abstracts of 58 articles:
HTML format

Single Articles

    November 2021
  1. VALLES E, Marti-Almor J, Grau N, Casteigt B, et al
    Influence of PACE score and conduction disturbances in the incidence of early new onset atrial fibrillation after typical atrial flutter ablation.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00288.
    PubMed     Abstract available

  2. WANG Y, Shao C, Qi L, Tan J, et al
    EphrinB2-RhoA upregulation attenuates sympathetic hyperinnervation and decreases the incidence of ventricular arrhythmia after myocardial infarction.
    J Cardiol. 2021 Nov 5. pii: S0914-5087(21)00290.
    PubMed     Abstract available

  3. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    PubMed     Abstract available

  4. LAO N, Lim J, Bashir H, Mahalwar G, et al
    Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019.
    J Cardiol. 2021 Nov 1. pii: S0914-5087(21)00305.
    PubMed     Abstract available

    October 2021
  5. NAGANO T, Yasuoka R, Tanaka M, Maruyama M, et al
    A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 29. pii: S0914-5087(21)00244.
    PubMed     Abstract available

  6. OBAYASHI Y, Miyake M, Amano M, Kitai T, et al
    Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 26. pii: S0914-5087(21)00273.
    PubMed     Abstract available

  7. TU T, Li B, Li X, Zhang B, et al
    Dietary omega-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation.
    J Cardiol. 2021 Oct 23. pii: S0914-5087(21)00207.
    PubMed     Abstract available

  8. WEI F, Ren W, Zhang X, Wu P, et al
    miR-425-5p is negatively associated with atrial fibrosis and promotes atrial remodeling by targeting CREB1 in atrial fibrillation.
    J Cardiol. 2021 Oct 20. pii: S0914-5087(21)00253.
    PubMed     Abstract available

  9. FUKUSHIMA S, Suzuki K, Kawamoto N, Kakuta T, et al
    Launching minimally invasive stand-alone maze procedure for atrial fibrillation.
    J Cardiol. 2021 Oct 5. pii: S0914-5087(21)00256.
    PubMed     Abstract available

  10. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.

    September 2021
  11. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available

  12. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    PubMed     Abstract available

    August 2021
  13. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available

  14. UKITA K, Egami Y, Kawamura A, Nakamura H, et al
    Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00199.
    PubMed     Abstract available

    July 2021
  15. TOHOKU S, Bordignon S, Chen S, Bologna F, et al
    Validation of lesion durability following pulmonary vein isolation using the new third-generation laser balloon catheter in patients with recurrent atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00167.
    PubMed     Abstract available

  16. LAI SW
    Urine dipstick proteinuria and atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00179.

  17. SAIRAKU A, Morishima N, Amioka M, Maeda J, et al
    Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era.
    J Cardiol. 2021 Jul 10. pii: S0914-5087(21)00165.
    PubMed     Abstract available

    June 2021
  18. RAMESH T, Lee PYK, Mitta M, Allencherril J, et al
    Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2021 Jun 20. pii: S0914-5087(21)00151.
    PubMed     Abstract available

  19. TAKAHIRA H, Kajiyama T, Kondo Y, Nakano M, et al
    Pathophysiological background and prognosis of common atrial flutter in non-elderly patients: Comparison to Atrial Fibrillation.
    J Cardiol. 2021 Jun 14. pii: S0914-5087(21)00132.
    PubMed     Abstract available

    Cardiac reverse remodeling following catheter ablation of atrial fibrillation.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00134.

  21. KUSUNOSE K, Takahashi H, Nishio S, Hirata Y, et al
    Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source.
    J Cardiol. 2021 Jun 9. pii: S0914-5087(21)00129.
    PubMed     Abstract available

  22. IWANO T, Toda H, Nakamura K, Shimizu K, et al
    Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00113.
    PubMed     Abstract available

  23. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available

  24. ABE Y, Takahashi Y, Shibata T
    A new disease entity: Atrial functional mitral regurgitation.
    J Cardiol. 2021;77:565-569.
    PubMed     Abstract available

    May 2021
  25. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available

    April 2021
  26. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available

  27. OKISHIGE K, Yamauchi Y, Nagase S, Kusano K, et al
    Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
    J Cardiol. 2021;77:380-387.
    PubMed     Abstract available

  28. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    PubMed     Abstract available

  29. TOPAZ G, Ben-Zvi E, Pereg D, Kitay-Cohen Y, et al
    Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain.
    J Cardiol. 2021;77:370-374.
    PubMed     Abstract available

    March 2021
  30. YAGI N, Suzuki S, Nagai K, Tanaka T, et al
    Current status of oral anticoagulant adherence in Japanese patients with atrial fibrillation: A claims database analysis.
    J Cardiol. 2021 Mar 2. pii: S0914-5087(21)00043.
    PubMed     Abstract available

  31. INOUE K, Hirao K, Kumagai K, Kimura M, et al
    Long-term efficacy and safety of anticoagulation after atrial fi brillation ablation: data from the JACRE registry.
    J Cardiol. 2021;77:263-270.
    PubMed     Abstract available

    February 2021
  32. SHINOHARA M, Wada R, Yano K, Akitsu K, et al
    Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants.
    J Cardiol. 2021;77:147-153.
    PubMed     Abstract available

  33. WILLY K, Dechering DG, Reinke F, Bogeholz N, et al
    The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications.
    J Cardiol. 2021;77:154-159.
    PubMed     Abstract available

  34. KISHIMA H, Mine T, Fukuhara E, Ishihara M, et al
    Left ventricular stiffness assessed by diastolic Wall strain predicts asymptomatic atrial high-rate episodes in patients with pacemaker implantation.
    J Cardiol. 2021;77:195-200.
    PubMed     Abstract available

  35. CHEN JY, Lu WD
    Duration of atrial high-rate episodes and CHA2DS2-VASc score to predict cardiovascular and cerebrovascular events in patients with dual chamber permanent pacemakers.
    J Cardiol. 2021;77:166-173.
    PubMed     Abstract available

    January 2021
  36. KIMATA A, Nogami A, Yamasaki H, Ohigashi T, et al
    Optimal interruption time of dabigatran oral administration to ablation (O-A time) in patients with atrial fibrillation: Integrated analysis of 2 randomized controlled clinical trials.
    J Cardiol. 2021 Jan 25. pii: S0914-5087(20)30414.
    PubMed     Abstract available

  37. YAGI N, Itoh H, Hisamatsu T, Tomita Y, et al
    Corrigendum to "A challenge for mutation specific risk stratification in long QT syndrome type 1" [J. Cardiol. 72(1) (2018) 56-65].
    J Cardiol. 2021 Jan 1. pii: S0914-5087(20)30313.

    November 2020
  38. OKADA M, Tanaka N, Oka T, Tanaka K, et al
    Clinical significance of left ventricular reverse remodeling after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction.
    J Cardiol. 2020 Nov 30. pii: S0914-5087(20)30368.
    PubMed     Abstract available

  39. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
    Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
    PubMed     Abstract available

  40. HATA R, Kato T, Yaku H, Morimoto T, et al
    Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
    J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
    PubMed     Abstract available

    September 2020
  41. NAKAMURA M, Yamashita T, Hayakawa A, Matsumoto T, et al
    Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study.
    J Cardiol. 2020 Sep 14. pii: S0914-5087(20)30293.
    PubMed     Abstract available

  42. KOBAYASHI S, Yoshiga Y, Yano M
    Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
    J Cardiol. 2020;76:323-324.

    August 2020
  43. MEHRAN R, Vogel B, Levy P
    Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.
    J Cardiol. 2020 Aug 26. pii: S0914-5087(20)30258.
    PubMed     Abstract available

  44. TANAKA Y, Tada H, Hara S, Hayashi K, et al
    Association of proteinuria with incident atrial fibrillation in the general Japanese population.
    J Cardiol. 2020 Aug 23. pii: S0914-5087(20)30277.
    PubMed     Abstract available

  45. KOSIUK J, Langenhan K, Hindricks G, Bollmann A, et al
    Remote ischemic preconditioning in a setting of electrical cardioversion of early onset persistent atrial fibrillation (RIP CAF trial): Rationale and study design.
    J Cardiol. 2020 Aug 23. pii: S0914-5087(20)30272.
    PubMed     Abstract available

  46. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed     Abstract available

  47. KOSHIYAMA M, Tamaki K, Ohsawa M
    Age-specific incidence rates of atrial fibrillation and risk factors for the future development of atrial fibrillation in the Japanese general population.
    J Cardiol. 2020 Aug 13. pii: S0914-5087(20)30263.
    PubMed     Abstract available

  48. NISHIMURA S, Izumi C, Yamasaki S, Obayashi Y, et al
    Impact of right ventricular function on development of significant tricuspid regurgitation in patients with chronic atrial fibrillation.
    J Cardiol. 2020 Aug 3. pii: S0914-5087(20)30152.
    PubMed     Abstract available

    July 2020
  49. MIYAZAKI A, Negishi J, Hayama Y, Tsuda E, et al
    Etiology of atrial fibrillation in patients with complex congenital heart disease - for a better treatment strategy.
    J Cardiol. 2020 Jul 20. pii: S0914-5087(20)30192.
    PubMed     Abstract available

  50. OKAWA K, Miyoshi T, Sogo M, Hara S, et al
    Improvement in renal and endothelial function after catheter ablation in patients with persistent atrial fibrillation.
    J Cardiol. 2020 Jul 15. pii: S0914-5087(20)30224.
    PubMed     Abstract available

  51. CAFFREY JL, Wu CK, Chang CH, Lin JW, et al
    Analysis of mortality risk following receipt of implantable cardioverter defibrillators in patients with and without heart failure.
    J Cardiol. 2020 Jul 15. pii: S0914-5087(20)30184.
    PubMed     Abstract available

  52. PHAM VT, Lin C, Tran TT, M Su MY, et al
    Predicting ventricular tachyarrhythmia in patients with systolic heart failure based on texture features of the gray zone from contrast-enhanced magnetic resonance imaging.
    J Cardiol. 2020 Jul 13. pii: S0914-5087(20)30222.
    PubMed     Abstract available

  53. LIU SH, Lo LW, Tsai TY, Cheng WH, et al
    Circadian rhythm dynamics on multiscale entropy identifies autonomic dysfunction associated with risk of ventricular arrhythmias and near syncope in chronic kidney disease.
    J Cardiol. 2020 Jul 3. pii: S0914-5087(20)30179.
    PubMed     Abstract available

  54. OKUMURA K, Yamashita T, Akao M, Atarashi H, et al
    Characteristics and anticoagulant treatment status of elderly non-valvular atrial fibrillation patients with a history of catheter ablation in Japan: Subanalysis of the ANAFIE registry.
    J Cardiol. 2020 Jul 2. pii: S0914-5087(20)30209.
    PubMed     Abstract available

    May 2020
  55. KAWAKAMI S, Yasuda S, Ogawa H
    Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen.
    J Cardiol. 2020 May 7. pii: S0914-5087(20)30091.
    PubMed     Abstract available

  56. WILLY K, Reinke F, Bogeholz N, Ellermann C, et al
    The role of entirely subcutaneous ICD systems in patients with dilated cardiomyopathy.
    J Cardiol. 2020;75:567-570.
    PubMed     Abstract available

    April 2020
  57. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    The genesis of ventricular arrhythmias in heart failure patients is based on alterations in cardiac mechanical, morphological, metabolic, electrophysiological properties, and neurohumoral remodeling.
    J Cardiol. 2020 Apr 22. pii: S0914-5087(20)30104.

  58. IZUMI C
    Isolated functional tricuspid regurgitation: When should we go to surgical treatment?
    J Cardiol. 2020;75:339-343.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.